Physician profile
Michael Jacobs
NPI 1447239793
$10,625.15
in general payments reported to CMS, 2019-2025
35 companies · $1,214 in 2025
The $1,214 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $246 · 2021: $1,592 · 2022: $1,728 · 2023: $2,573 · 2024: $2,734 · 2025: $1,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,372 · Travel and Lodging: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,371.87 |
| Travel and Lodging | $1,150.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,705.22 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Abbvie INC. | $677.48 | 2022-2025 | |
| Relievant Medsystems, INC. | $568.98 | 2023 | Intracept |
| Vertos Medical, INC. | $558.65 | 2021-2024 | Mild Device Kit |
| Nevro Corp. | $493.18 | 2020-2024 | Senza |
| Boston Scientific Corporation | $376.52 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $357.29 | 2019-2025 | Proclaim |
| Grt US Holding, INC. | $300.96 | 2021-2022 | |
| Medtronic USA, INC. | $284.75 | 2019-2020 | |
| Lundbeck LLC | $232.32 | 2022-2024 | Vyepti |
| Collegium Pharmaceutical, INC. | $226.44 | 2022-2024 | Xtampza, Belbuca |
| Bioventus LLC | $205.79 | 2021-2022 | |
| Foundation Fusion Solutions, LLC | $191.67 | 2022 | |
| Lilly USA, LLC | $170.96 | 2022-2023 | Reyvow, Emgality |
| Depuy Synthes Sales INC. | $160.89 | 2024-2025 | Attune, Orthovisc |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $159.58 | 2022 | |
| Spr Therapeutics, INC | $115.69 | 2020-2025 | Sprint Pns System |
| Biotronik Nro, INC. | $106.16 | 2023-2025 | Prospera, Biotronik |
| Spinal Simplicity, LLC | $88.60 | 2022 | |
| Impel Pharmaceuticals INC. | $86.93 | 2023 | Trudhesa |
| Pacira Pharmaceuticals Incorporated | $86.20 | 2023-2024 | Iovera, Zilretta, Exparel |
| Pfizer INC. | $67.47 | 2023 | |
| Fidia Pharma USA INC. | $61.70 | 2024-2025 | Hymovis, Triluron |
| Idorsia Pharmaceuticals US INC | $61.64 | 2022-2023 | Quviviq |
| Vertex Pharmaceuticals Incorporated | $44.29 | 2024 | |
| Averitas Pharma INC. | $39.78 | 2023-2024 | Qutenza |
| Cumberland Pharmaceuticals, INC. | $30.37 | 2024 | Kristalose |
| Biohaven Pharmaceutical Holding Company Ltd. | $25.82 | 2022 | |
| Almatica Pharma LLC | $24.84 | 2022 | |
| Curonix LLC | $21.77 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $21.25 | 2024 | |
| Impel Pharmaceuticals LLC | $20.61 | 2024 | Trudhesa |
| Janssen Pharmaceuticals, INC | $19.91 | 2024 | Xarelto |
| Sunovion Pharmaceuticals INC. | $15.72 | 2019 | |
| Avanos Medical | $15.72 | 2024 | Standard Rf Disposables |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.